Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Ian Nivison-Smith"'
Autor:
David Kliman, Nada Hamad, Duncan Purtill, Ian Nivison-Smith, Ian Kerridge, David Gottlieb, Jeff Szer, David D.F. Ma
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:1711-1718
The health and outcomes of long-term survivors after hematopoietic cell transplant (HCT) are areas of evolving interest as short-term transplant outcomes improve. Because recent changes in transplant practice have likely changed the survivor populati
Autor:
Howard Gurney, Peter Presgrave, Andrew J. McLachlan, Ian Kerridge, Ian Nivison-Smith, Douglas E. Joshua, Peter J. Shaw, Christa E. Nath, Judith Trotman, L. Zeng, Campbell Tiley
Publikováno v:
Bone Marrow Transplantation. 55:1862-1864
Autor:
Bunworasate U, Huynh Vm, Lie Akw, Alok Srivastava, Baylon H, Akter Mr, Minako Iida, Lallindra Gooneratne, Hye Jin Kang, Jih-Luh Tang, Yoshihisa Kodera, Ong Tc, Ho Ayl, Yoshiko Atsuta, A. Ghavamzadeh, Gyi Aa, S. Okamoto, Wu T, Ian Nivison-Smith, Anthony J. Dodds, Farzana T
Publikováno v:
Bone Marrow Transplant
Between 2005 and 2015, 138,165 hematopoietic stem cell transplantation (HSCT) were reported in 18 countries/regions in the Asia-Pacific region. In this report, we describe current trends in HSCT throughout the Asia-Pacific region and differences amon
Autor:
David Gottlieb, John Moore, Anthony J. Dodds, Ian Nivison-Smith, Glen A Kennedy, Nada Hamad, Jeff Szer, Sam Milliken, Duncan Purtill, D F David, Ashish Bajel, Ian Kerridge
Publikováno v:
Internal medicine journalReferences. 52(1)
Background Results have been varied regarding the effect of donor age on the outcome of unrelated donor hematopoietic cell transplantation (HCT). Aims This study sought to determine the influence of donor age on adult unrelated donor HCT outcome in A
Autor:
Arjan C. Lankester, Alice Bertaina, Andrew S. Moore, Birgitta Versluys, Jacek Wachowiak, Theodor Uden, Ian Nivison-Smith, Marc Ansari, Franco Locatelli, Kirsten Mischke, Martin Zimmermann, Henrik Hasle, Corinne Gerhardt, Jerry Stein, Leen Willems, Marc Bierings, Christina Peters, Martin Sauer, Jonas Abrahamsson, Dirk Reinhardt, Petr Sedlacek, Anna Pieczonka, Jean-Pierre Bourquin, Adriana Balduzzi
Publikováno v:
British journal of haematology, Vol. 189, No 4 (2020) pp. 745-750
Uden, T, Bertaina, A, Abrahamsson, J, Ansari, M, Balduzzi, A, Bourquin, J-P, Gerhardt, C, Bierings, M, Hasle, H, Lankester, A, Mischke, K, Moore, A S, Nivison-Smith, I, Pieczonka, A, Peters, C, Sedlacek, P, Reinhardt, D, Stein, J, Versluys, B, Wachowiak, J, Willems, L, Zimmermann, M, Locatelli, F & Sauer, M G 2020, ' Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia : a retrospective I-BFM analysis of 333 children ', British Journal of Haematology, vol. 189, no. 4, pp. 745-750 . https://doi.org/10.1111/bjh.16441
British Journal of Haematology. WILEY
British Journal of Haematology
Uden, T, Bertaina, A, Abrahamsson, J, Ansari, M, Balduzzi, A, Bourquin, J-P, Gerhardt, C, Bierings, M, Hasle, H, Lankester, A, Mischke, K, Moore, A S, Nivison-Smith, I, Pieczonka, A, Peters, C, Sedlacek, P, Reinhardt, D, Stein, J, Versluys, B, Wachowiak, J, Willems, L, Zimmermann, M, Locatelli, F & Sauer, M G 2020, ' Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia : a retrospective I-BFM analysis of 333 children ', British Journal of Haematology, vol. 189, no. 4, pp. 745-750 . https://doi.org/10.1111/bjh.16441
British Journal of Haematology. WILEY
British Journal of Haematology
Outcome of 333 children with acute myeloid leukaemia relapsing after a first allogeneic haematopoietic stem cell transplantation was analyzed. Four-year probability of overall survival (4y-pOS) was 14%. 4y-pOS for 122 children receiving a second haem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::857d4011eee946472e5bff2043cee0f4
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85078877303
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85078877303
Autor:
Sam Milliken, Ian Nivison-Smith, Sylvia Ai, Rodrigo Martino, Anthony J. Dodds, David D.F. Ma, Irene García-Cadenas, John Moore, Keith Fay, Chun Kei Kris Ma, Maria Laura Fox, Jorge Sierra
Publikováno v:
Bone Marrow Transplantation. 53:1478-1482
Autor:
Peter J. Shaw, Sam Milliken, Steven Tran, Anthony J. Dodds, David D.F. Ma, Leonie Wilcox, Ian Nivison-Smith, Jeff Szer, David Gottlieb, John Kwan
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:169-174
We conducted a study to analyze and report on indicators of hematopoietic cell transplant (HCT) physician time use and HCT center output measures. HCT centers in Australia and New Zealand (A&NZ) were invited to provide demographic and time use detail
Autor:
David D.F. Ma, William N. Patton, John M. Carter, Ian Nivison-Smith, Peter J. Shaw, Jeff Szer, Peter G Bardy, Leonie Wilcox, Andrew J. Butler, John Kwan, Anthony J. Dodds, Hilary Blacklock
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:147-152
A previous study found that platelet recovery and mortality were worse in recipients of myeloablative bone marrow transplants where graft transit times were longer than 20 hours. This retrospective study of unrelated myeloablative allogeneic transpla
Autor:
Tracey A. O'Brien, Ian Nivison-Smith, Chris Fraser, Heather Tapp, Andrew S. Moore, Francoise Mechinaud, Frank Alvaro, Peter J. Shaw, Adrian G. Selim, Lochie Teague, Catherine H. Cole
Publikováno v:
Pediatric bloodcancer. 66(8)
Approximately one-third of children with acute myeloid leukemia (AML) relapse, requiring re-treatment and allogeneic hematopoietic stem cell transplantation (HSCT). Although achieving second complete remission (CR2) prior to HSCT is desirable, once C
Autor:
Simon Durrant, David D.F. Ma, P Kruger, Jeff Szer, Anthony J. Dodds, Julian Cooney, Ian Nivison-Smith, Peter G Bardy
Publikováno v:
Bone Marrow Transplantation. 51:1400-1403
All is not lost in accelerated phase/blast crisis and after tyrosine kinase inhibitors fail in chronic myeloid leukaemia: a retrospective study of allogeneic stem cell transplant outcomes in Australia and New Zealand